tissue type plasminogen activator (tPAurokinase (UKpro-urokinase (Pro-UKfibrinkringleIn view of the similarity of the charge distribution between fibrin A_伪148--161 and A chain 149--157 of urokinase,the latter might compete with fibrin A_伪148--161 when single chain pro-urokinase is ...
网络组织纤溶酶原激活物 网络释义 1. 组织纤溶酶原激活物 ...asminogen Activator,UPA)或组织纤溶酶原激活物(Tissue-plasminogen Activator,TPA)将纤溶酶原转化为纤溶酶,纤溶酶 … www.wiki8.com|基于14个网页
Recombinant Human Tissue Plasminogen Activator 供应商 ProSpec 产品货号 ENZ-263 产品报价 ￥询价/20ug 产品说明书 点击查看 购买方式 在线支付宝及网银支付、支票、现金、电汇,或拨打全国免费服务电话4006800868与我们联系. 产品新闻 背景资料 Tissue plasminogen activator(abbreviated PLAT or tPA) is a secreted ser...
提供的Tissue Plasminogen Activator (tPA), Recombinant, Mouse (Biotin)来源为Recombinant, Insect cell culture。 溶解建议 艾美捷向您提供的USBiological品牌Tissue Plasminogen Activator (tPA), Recombinant, Mouse (Biotin)产品为原装进口产品。请按照产品说明书进行后继操作。
英文名称: Recombinant Human Tissue Plasminogen Activator(tPA) 总访问: 638 国产/进口: 进口 半年访问: 3 产地/品牌: Cali-Bio 产品类别: 细胞生物学试剂 规格: 1mg 最后更新: 2024-12-5 货号: CAS 号: 参考报价: 16800元 立即询价 电话咨询 ...
PLAT; T-PA; t-plasminogen activator; Alteplase; ReteplaseCCC A525 HGNC 9051 MGI 97610 PubMed 19681102 RGD 3342 UniProt P00750 Wiki TPA Tissue plasminogen activator is a protein involved in the breakdown of blood clots. Specifically, it is a serine protease (EC 3.4.21.68) found on ...
Tissue plasminogen activator (tPA) is a drug given through a vein to help break up a blood clot so that blood flow can return to normal. It is used for the emergency treatment ofischemicstroke, which occurs when a blood clot interrupts blood flow to a region of the brain.1 ...
从人的黑素瘤细胞提取总RNA,进行RT-PCR,克隆了组织纤维溶酶原激活剂(tPA)基因,对其缺失突变,进一步克隆了溶栓药物瑞替普酶-reteplase(rPA)基因;以羊的β-乳球蛋白基因(BLG)作为调控序列,构建了瑞替普酶的乳腺表达载体BrPA。 3) recombinant human tissue plasminogen activator (tPA) ...
产品名称 Rat Tissue-type Plasminogen Activator (tPA) Active ELISA Assay Kit (Eagle Biosciences, CAT# TPA29-K0 货号: TPA29-K01 规格: 96T or More 品牌: Eagle Biosciences 价格: ￥请询价 产品分类: ELISA试剂盒 研究领域: 酶联免疫吸附实验 CAS编号: 分子量: 分子式: 别名: 储存条件: 4℃ ...
目的观察冠心病患者行冠状动脉介入治疗(PCI)手术前后血浆组织型纤溶酶原激活物(tPA)及纤溶酶原激活抑制剂(PAI)的动态变化。 2. Objective To explore the plasma concentration changes of tissue-type plasminogen activator(tPA),urokinasetype plasminogen activator(uPA),urokinasetype plasminogen activator receptor(uPA...